We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Molecular Method Quickly Identifies Antibiotic-Resistant Acinetobacter

By Biotechdaily staff writers
Posted on 11 Dec 2007
Acinetobacter baumannii, a bacterium widely found on our skin and in the environment, has now become a major threat in hospitals where it can cause serious infections, such as pneumonia in severely ill patients. More...
The new types Acinetobacter are resistant to nearly all antibiotics and three resistant strains are currently circulating in the United Kingdom. A molecular method for identifying the bacteria has been successfully developed.

The method, designed by the Health Protection Agency (London, UK), was successfully implemented by medical scientists at the Royal Free Hospital (Hampstead, UK). It is a quick and accurate means of identifying which strain of the bacterium is infecting a patient. The multiplex-polymerase chain reaction (PCR), based on identifying unique gene sequences in the bacteria, has the potential to be developed as a rapid screening tool for intensive care units in other parts of the country. It should eventually lead to better patient management with faster and more appropriate treatments for individuals and prompt control of infections to reduce the risk of transmission to other patients

The drug-resistant strains of the bacteria are especially dangerous in intensive care units where, as well as causing pneumonia, they can infect wounds, or cause urinary tract infections. "Some of these new strains of A. baumannii, known as epidemic clones, can spread rapidly and widely between patients and have the potential to cause outbreaks,” said Kerry Williams of the Royal Free Hospital. "We currently encounter two of them at our hospital, so we need a reliable and rapid means of identifying and discriminating between the different clones. We can now get a result from a patient's sample in just four hours. The test also allows us to predict how likely we are to be facing an outbreak.”

"Like MRSA, A. baumannii can be found on the skin without actually causing an infection. The new test is important because it means we can rapidly identify patients who are colonized with drug-resistant strains of the bacteria so that special infection control measures can be put in place. The patient can quickly be isolated if necessary,” added Miss Williams of the Royal Free Hospital. "This reduces the risk of transmission to other patients and the possibility of an outbreak occurring. The ability to distinguish between the clones circulating is also important because it allows us to monitor transmission in our hospital.”

Currently all the Royal Free Hospital strains of bacteria are sent to a reference laboratory for typing by a method called pulsed field gel electrophoresis. The new test, called multiplex-PCR, gives results comparable to the ones produced by the reference laboratory.

The method was described at the Federation of Infection Societies Conference 2007 in Cardiff (Wales,UK), on November 28, 2007.


Related Links:
Health Protection Agency
Royal Free Hospital

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.